| Financial Year |
March 31 2023 |
| Monetary Funds |
1,143,475,547.55 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
411,845,793.73 |
| Advances to Suppliers |
185,865,175.47 |
| Other Receivables |
31,814,696.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,168,826,325.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
20,618,157.72 |
| Other Current Assets |
182,124,380.81 |
| Total Current Assets |
3,144,570,077.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
195,537,449.13 |
| Long-term Equity Investment |
27,914,634.08 |
| Investment Properties |
24,688,234.81 |
| Fixed Assetes |
384,650,627.26 |
| Under-construction Projects |
54,707,338.50 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
207,335,493.28 |
| R&D expenses |
20,942,064.53 |
| Goodwill |
108,564,569.24 |
| Long-Term Deferred and Prepaid Expenses |
88,168,585.08 |
| Deferred Income Tax Assets |
3,824,320.10 |
| Other Non-Current Assets |
29,144,302.17 |
| Sub-Total of Non-Current Assets |
1,438,240,310.86 |
| Total Assets |
4,582,810,388.56 |
| Short-Term Loans |
588,673,396.14 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
301,382,692.22 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,724,856.00 |
| Taxes Payable |
2,524,508.12 |
| Interest Payable |
-- |
| Dividend Payable |
919,674.49 |
| Other payables |
185,087,017.82 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
78,049,790.48 |
| Other Current Liabilities |
294,825,799.30 |
| Sub-Total of Current Liabilities |
1,817,283,277.59 |
| Long-term Loans |
125,138,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
519,831,752.57 |
| Total Liabilities |
2,337,115,030.16 |
| Paid-In Capital(Or Share Stock) |
676,665,537.00 |
| Capital Surplus |
391,881,695.21 |
| Surplus Reserve |
26,953,306.75 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
629,985,543.75 |
| Minority Stockholder's Interest |
493,617,446.42 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,752,077,911.98 |
| Owner's Equity（Stockholder's Equity） |
2,245,695,358.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,582,810,388.56 |
